HomeRYI • FRA
add
Viracta Therapeutics Inc
Previous close
€0.43
Day range
€0.49 - €0.49
Year range
€0.24 - €1.40
Market cap
20.71M USD
Avg Volume
100.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 13.88M | 13.67% |
Net income | -9.14M | 25.13% |
Net profit margin | — | — |
Earnings per share | -0.23 | 28.12% |
EBITDA | -13.77M | -13.91% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 39.57M | -50.97% |
Total assets | 41.33M | -51.81% |
Total liabilities | 30.25M | -12.73% |
Total equity | 11.08M | — |
Shares outstanding | 39.27M | — |
Price to book | 3.10 | — |
Return on assets | -70.78% | — |
Return on capital | -94.00% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -9.14M | 25.13% |
Cash from operations | -7.85M | 30.78% |
Cash from investing | 14.19M | 293.09% |
Cash from financing | -6.60M | -41,337.50% |
Net change in cash | -255.00K | 98.63% |
Free cash flow | -8.93M | -27.43% |
About
Founded
1998
Website
Employees
40